According to a new market report published by Transparency Market Research, "Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018," the global market for radiopharmaceuticals was valued at approximately USD 3.8 billion in 2011 and is expected to reach USD 12.2 billion by 2018 at a CAGR of 18.3% from 2012 to 2018. North America led the global radiopharmaceuticals market with the highest market share as Canada continues to be the largest exporter of uranium and nuclear technology, forming the backbone of nuclear medicine and imaging studies. To Buy And Browse Full Report With TOC at : http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html

1. REPORT DESCRIPTION
Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And
Forecast, 2012 - 2018
The Radiopharmaceuticals imply the usage of radiation for non-invasive treatment and
diagnosis of various diseases. Utilization of these molecules for medical purposes in PET and
SPECT imaging has changed the entire algorithm of disease diagnosis. With rise in the aging
population globally coupled with increasing rate of chronic cardiovascular, oncology and
neurology diseases, there is tremendous growth potential in this market, especially in
developing nations. Similarly, the use of radiolabeled isotopes with peptides and monoclonal
antibodies has opened new boulevards for the growth of the global radiopharmaceuticals
market. Many radiopharmaceuticals use technetium-99m (Tc-99m) that has many useful
properties of gamma-emitting tracer nuclide.
Radiopharmaceuticals are majorly used to diagnose cancer, tumors, biliary tract blockage,
bone diseases, bone marrow diseases, brain diseases, colorectal disease, disorders of iron
metabolism and absorption, heart disease, heart muscle damage (infarct), impaired flow of
cerebrospinal fluid in the brain, kidney diseases, liver diseases, lung diseases, parathyroid
Transparency Market Research
Radiopharmaceuticals
Market - Global Industry
Analysis, Size, Share,
Trends And Forecast, 2012
- 2018
Single User License: US $ 5595
Multi User License: US $ 8595
Corporate User License: US $ 11595
Buy Now
Request Sample
Published Date: Feb 2013
119 Pages Report

2. diseases, parathyroid cancer, pernicious anemia, improper absorption of vitamin B12 from
intestines, red blood cell diseases, salivary gland diseases, spleen diseases, stomach and
Browse Report : Radiopharmaceuticals Market
intestinal bleeding, stomach problems, tear duct blockage, thyroid diseases, thyroid cancer
and urinary bladder diseases.
This may be given to the patient in a number of ways, for e.g. they may be given through
the mouth, through injections or placed into the eye or into the bladder. It is a small
treatment, which includes use of simple substances containing radioactive isotopes. While
treating cancer, these radioactive agents are taken up in the cancerous area to destroy the
affected tissues. It works effectively by targeting the areas in the body where the cancer is
present. Individuals are suggested to intake radiopharmaceuticals only under the direct
supervision of a doctor.
This report analyses the global scenario of the radiopharmaceuticals market, discussing
detailed overview and market figures. The research report analyses the industry growth
rate, industry capacity, and industry structure. The report analyses the historical data, and
forecasts the radiopharmaceuticals market size, production forecasts along with key factors
driving and restraining the market.
The report also analyzes the radiopharmaceuticals market by generators and by further
classifying them in terms of medical isotopes, their applications, end users and geographic
distribution. The medical isotopes category covers major isotopes used in SPECT and PET
imaging like technetium, thallium, gallium, rhenium, yttrium and others. The applications
market is further classified into diagnosis and therapy. The end user analysis is done by
bifurcation of the market into hospitals and outpatient diagnostic centers.
The geography market has been segmented into four major regions - North America,
Europe, Asia-Pacific and Rest of the World (RoW). Some of the top radiopharmaceutical
companies in the healthcare market are Covidien Plc, Nordion Inc., Lantheus Medical
Imaging, IBA Group, Positron Corporation, Cardinal Health, Eckert & Ziegler among others.
The study presents a comprehensive assessment of the stakeholder strategies, winning
imperatives for them by segmenting the radiopharmaceuticals market as below:
Radiopharmaceuticals Market by Generator Types
 Mo-99/Tc-99m generator
 Sr-82/Rb-82 generator
 Ge-68/Ga-68 generator
 Sr-90/Y-90 generator
 W-188/Re-188 generator

3. Browse Report :
http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html
Radiopharmaceuticals Market by End-Users
 Hospitals & Medical Centers
 Diagnostic Centers
Radiopharmaceuticals Market by Applications
 Diagnosis
 Diagnosis by Technique
o SPECT
 Technetium (Tc-99m)
 Thallium (TI-201)
 Gallium (Ga-67)
 Iodine (I-123)
 Rhenium (Re-186)
 Yttrium (Y-90)
 Others/li>
o PET
 Fludeoxyglucose (18F-FDG)
 Rubidium (Rb-82)
 Others (Carbon-11 choline, Nitrogen-13 ammonia)
Diagnosis by Indications
 Oncology
 Cardiovascular
 Others (Neurological, Thyroid, Gastrointestinal)
Therapy
 Systemic Oncology

4. o Iodine (I-131)
o Yttrium (90Y)
o Samarium (Sm-153)
o Strontium (89Sr)
o Rhenium (186Re)
o Lutetium (Lu-177)
o Erbium (169Er)
o Others
 Others (Cardiology, Neurology)
Radiopharmaceuticals Market by Geography
 North America
 Europe
 Asia-Pacific
 Rest of the World (RoW)
TABLE OF CONTENTS
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
Browse Report :
http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html
Chapter 3 Global Radiopharmaceuticals Market Overview
3.1 Overview

5. 3.2 Market Drivers
3.2.1 Radiopharmaceutical-Based Cancer Therapy
3.2.2 Growing Preference For Disease-Targeted Therapy
3.2.3 Increasing Awareness Of Accurate Diagnosis
3.2.4 Expanding Molecular Imaging Applications
3.3 Market Restraints
3.3.1 Strict Regulatory Guidelines For Production, Storage and Usage
3.3.2 Worldwide Supply Shortages
3.3.3 Price Sensitivity And Competitive Alternatives
3.4 Market Opportunities
3.4.1 Increasing Demand For Accurate Diagnosis and Treatment, Particularly In
Emerging Markets
3.4.2 Radiopharmaceutical-Based Personalized Therapy
Chapter 4 Market Definition & Supply Chain Analysis
4.1 Market Definition
4.2 Radiopharmaceutical Production : A Global Perspective
4.3 Supply Chain Analysis
Chapter 5 Global Radiopharmaceutical Generators Market
5.1 Overview
5.1.1 Global Radiopharmaceutical Generators Market, By Revenue, 2010-2018 (USD
Million)
5.2 Mo-99/Tc-99m Generators
5.3 Sr-82/Rb-82 Generators
5.4 Ge-68/Ga-67,68 Generators
5.5 Sr-90/Y-90 Generators
5.6 W-188/Re-188 Generators

6. Browse Report :
http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html
Chapter 6 Global Radiopharmaceuticals Market, By End-User Groups
6.1 Overview
6.1.1 Global Radiopharmaceuticals Market By End Users, By Revenue, 2010-2018 (USD
Million)
6.2 Hospitals and Medical Centers
6.2.1 Global Radiopharmaceuticals Market By End User Groups : Hospitals and Medical
Centres, 2010 – 2018 (USD Million)
6.3 Outpatient Diagnostic Centers
6.3.1 Global Radiopharmaceuticals Market By End User Groups: Diagnostic Centres,
2010 – 2018 (USD Million)
Chapter 7 Global Radiopharmaceuticals Market, By Applications
7.1 Overview
7.2 Radiopharmaceuticals For Diagnosis
7.2.1 Overview
7.2.2 Radiopharmaceuticals For Diagnosis, By Technique
7.2.2.1 Single-Photon Emission Computed Tomography (SPECT)
7.2.2.1.1 Comparative Analysis: SPECT Radioisotopes Market, 2011 &
2018 (%)
7.2.2.1.2 Technetium (Tc-99m)
7.2.2.1.3 Thallium (Tl-201)
7.2.2.1.4 Gallium (Ga-67)
7.2.2.1.5 Iodine (I-123)
7.2.2.1.6 Rhenium (Re-186)
7.2.2.1.7 Yttrium (Y-90)
7.2.2.1.8 Others

7. 7.2.2.2 Positron Emission Tomography (PET)
7.2.2.2.1 Comparative Analysis: PET Radioisotopes Market, 2011 & 2018
(%)
7.2.2.2.2 Fludeoxyglucose (18f-FDG)
7.2.2.2.3 Rubidium (Rb-82)
7.2.2.2.4 Others (Carbon-11 Choline, Nitrogen13 Ammonia)
7.2.3 Radiopharmaceuticals For Diagnosis, By Indications
7.2.3.1 Oncology
7.2.3.2 Cardiovascular
7.2.3.3 Others (Neurological, Thyroid, Gastrointestinal)
7.3 Radiopharmaceuticals For Therapy
7.3.1 Overview
7.3.2 Oncology (Systemic Therapy)
7.3.2.1 Comparative Analysis: Systemic Therapy Radioisotopes Market, 2011 &
2018 (%)
7.3.2.2 Iodine (I-131)
7.3.2.3 Yttrium (Y-90)
7.3.2.4 Samarium (Sm-153)
7.3.2.5 Strontium (Sr-89)
7.3.2.6 Rhenium (186Re)
7.3.2.7 Lutetium-177 (Lu-177)
7.3.2.8 Erbium-169 (169Er)
7.3.2.9 Others
7.3.3 Other Applications In Therapy (Cardiology, Neurology)
7.4 Theranostics
Browse Report :
http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html
Chapter 8 Global Radiopharmaceuticals Market, By Geography

8. 8.1 Overview
8.2 North America
8.2.1 North America Radiopharmaceuticals Market - Diagnosis and Systemic Therapy,
2010-2018 (USD Million)
8.2.2 North America Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
8.3 Europe
8.3.1 Europe Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-
2018 (USD Million)
8.3.2 Europe Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
8.4 Asia-Pacific (Apac)
8.4.1 Asia-Pacific Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-
2018 (USD Million)
8.4.2 Asia-Pacific Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
8.5 Rest of the World (RoW)
8.5.1 RoW Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018
(USD Million)
8.5.2 RoW Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
Chapter 9 Market Share Analysis By Key Players
9.1 Radiopharmaceuticals Market
9.2 Generators Market
Browse Report :
http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html
Chapter 10 Recommendations
10.1 Identification and Elimination Of Barriers
10.2 Development of Total Solutions
10.3 Investing in Emerging Markets
10.4 Entering Monopoly Markets

9. Chapter 11 Company Profiles
11.1 Cardinal Health Inc.
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Business Strategies
11.1.3.1 Mergers and Acquisitions
11.1.3.2 External Funding
11.1.3.3 Incorporation of Advanced Technologies to Support Business
Development
11.1.4 Product Portfolio
11.1.5 Recent Developments
11.2 Covidien Plc
11.2.1 Company Overview
11.2.2 Product Portfolio
11.2.3 Financial Overview
11.2.4 Strategic Overview
11.2.4.1 Mergers and Acquisitions
11.2.4.2 Approvals
11.2.5 Recent Developments
11.3 GE Healthcare
11.3.1 Company Overview
11.3.2 Product Portfolio
11.3.3 Financial Overview
11.3.4 Strategic Overview
11.3.4.1 Mergers and Acquisitions
11.3.5 Recent Developments

10. 11.4 IBA Group
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Product Portfolio
11.5 Lantheus Medical Imaging
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Business Strategies
11.5.3.1 Rigorous Research and Development Initiatives
11.5.3.2 Selling Generic Products to Maintain Market Share
11.5.4 Product Portfolio
11.5.4.1 Recent Developments
11.6 Monrol Nuclear Products, Inc.
11.6.1 Company Overview
11.6.2 Product Portfolio
11.6.3 Strategic Overview
11.6.3.1 Mergers and Acquisitions
11.6.3.2 Collaborations
11.6.4 Recent Developments
11.7 Nordion, Inc.
11.7.1 Company Overview
11.7.2 Product Portfolio
11.7.3 Financial Overview
11.7.4 Strategic Overview
11.7.4.1 Contracts and Agreements
11.7.4.2 Divestiture
11.7.5 Recent Developments

11. 11.7.5.1 New Product Launch
11.8 NTP Radioisotopes (Pty) Ltd
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Business Strategies
11.8.3.1 Media Campaigns as a Brand Management Tool
11.8.3.2 Business Expansion through Partnerships, Collaborations and Alliances
11.8.4 Product Portfolio
11.8.5 Recent Developments
11.9 Polatom
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Business Strategies
11.9.3.1 Maintaining an Extensive Network of Distributors
11.9.4 Product Portfolio
11.9.5 Recent Developments
11.10 Positron Corporation
11.10.1 Company Overview
11.10.2 Product Portfolio
11.10.3 Financial Overview
11.10.4 Strategic Overview
11.10.4.1 Contracts and Agreements
11.10.4.2 Collaborations
11.10.5 Recent Developments
11.10.5.1 Grants and Licenses
11.10.5.2 Incentives
11.11 Siemens Healthcare

12. 11.11.1 Company Overview
11.11.2 Financial Overview
11.11.3 Business Strategies
11.11.3.1 Investing In Emerging Economies
11.11.3.2 Rigorous Research and Development Initiatives
11.11.3.3 Identifying Key Growth Areas and Determining Short Term Goals
(Agenda 2013)
11.11.3.4 Maintaining An Extensive Suppliers Network
11.11.4 Product Portfolio
11.11.5 Recent Developments
About Us:
Transparency Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants,
who use proprietary data sources and various tools and techniques to gather, and analyze
information. Our business offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/